171 related articles for article (PubMed ID: 19035875)
1. Allopurinol treatment reduces arterial wave reflection in stroke survivors.
Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
Cardiovasc Ther; 2008; 26(4):247-52. PubMed ID: 19035875
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats.
Yamamoto Y; Ogino K; Igawa G; Matsuura T; Kaetsu Y; Sugihara S; Matsubara K; Miake J; Hamada T; Yoshida A; Igawa O; Yamamoto T; Shigemasa C; Hisatome I
Hypertens Res; 2006 Nov; 29(11):915-21. PubMed ID: 17345792
[TBL] [Abstract][Full Text] [Related]
3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
4. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
George J; Struthers AD
Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
[TBL] [Abstract][Full Text] [Related]
5. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
George J; Carr E; Davies J; Belch JJ; Struthers A
Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial.
Muir SW; Harrow C; Dawson J; Lees KR; Weir CJ; Sattar N; Walters MR
Stroke; 2008 Dec; 39(12):3303-7. PubMed ID: 18845806
[TBL] [Abstract][Full Text] [Related]
7. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.
Dawson J; Quinn TJ; Harrow C; Lees KR; Walters MR
Br J Clin Pharmacol; 2009 Nov; 68(5):662-8. PubMed ID: 19916990
[TBL] [Abstract][Full Text] [Related]
8. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
[TBL] [Abstract][Full Text] [Related]
9. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
Feig DI; Soletsky B; Johnson RJ
JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
11. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
12. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
13. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
[TBL] [Abstract][Full Text] [Related]
14. The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.
Britnell SR; Chillari KA; Brown JN
Curr Vasc Pharmacol; 2018; 16(6):583-588. PubMed ID: 28933307
[TBL] [Abstract][Full Text] [Related]
15. Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial.
Hu J; Jiang X; Li N; Yu X; Perkovic V; Chen B; Zhao L; Neal B; Wu Y
Hypertens Res; 2009 Apr; 32(4):282-8. PubMed ID: 19262499
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol initiation and change in blood pressure in older adults with hypertension.
Beattie CJ; Fulton RL; Higgins P; Padmanabhan S; McCallum L; Walters MR; Dominiczak AF; Touyz RM; Dawson J
Hypertension; 2014 Nov; 64(5):1102-7. PubMed ID: 25135183
[TBL] [Abstract][Full Text] [Related]
17. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods.
Baulmann J; Schillings U; Rickert S; Uen S; Düsing R; Illyes M; Cziraki A; Nickering G; Mengden T
J Hypertens; 2008 Mar; 26(3):523-8. PubMed ID: 18300864
[TBL] [Abstract][Full Text] [Related]
18. [Blood antioxidant capacity in gout].
Tsutsumi Z; Yamamoto T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():465-9. PubMed ID: 12629767
[No Abstract] [Full Text] [Related]
19. The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors.
Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
Atherosclerosis; 2008 Oct; 200(2):374-9. PubMed ID: 18242617
[TBL] [Abstract][Full Text] [Related]
20. Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
Doria A; Galecki AT; Spino C; Pop-Busui R; Cherney DZ; Lingvay I; Parsa A; Rossing P; Sigal RJ; Afkarian M; Aronson R; Caramori ML; Crandall JP; de Boer IH; Elliott TG; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Maahs DM; McGill JB; Molitch ME; Perkins BA; Polsky S; Pragnell M; Robiner WN; Rosas SE; Senior P; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M;
N Engl J Med; 2020 Jun; 382(26):2493-2503. PubMed ID: 32579810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
